Graphene to Play a Vital Role in the Development of Biosensor Technology
In recent decades, there has been an increase of possibilities in the use of conducting polymers, carbon nanotubes, and graphene for building novel biosensors, due to the advancement of polymers and carbon nanomaterials. The use of polymers, CNTs and graphene as sensor components, due to their exceptional features, are intended to make sensors increasingly trustworthy, precise and speedy. Various techniques can be employed to design sensing devices based on the type of target molecule.
Point of care (POC) testing and diagnostics are a major growth area for biosensors, enabling remote health monitoring in real-time. Biosensor systems are used to detect diseases and infections, including diabetes, heart disorders, cancer, and contagious diseases more conveniently, efficiently and sensitively. Biosensor opportunities will also be pushed by the increased spread of mobile telephones to make health data easier to communicate.
Wearable biosensors discover expanding possibilities in remote places, which do not include medical and healthcare facilities, to continue monitoring of vital signs of patients, preterm infants, children, athletes, or fitness enthusiasts.
Factors influencing development and adoption - Key drivers and challenges
- Patent landscape
- Funding Insights
- R&D ecosystem
- Key growth opportunities
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Archer Materials
- Cardea Bio
- Grapheal
- HeMemics Biotechnologies
- Sparc Technologies Limited